BN Business News
Add your company to Business Communicator →

Business · 19/01/1996Updated: 10/18/2026 · 1 min read

FDA Announces Public Workshop on Creutzfeldt-Jakob Disease Transmission via Plasma and Plasma Derivatives

Summary

The FDA is hosting a public workshop to discuss experimental study designs for investigating the possible transmission of Creutzfeldt-Jakob Disease by plasma and plasma-derived products, with the goal of advancing laboratory methods for this research.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →